Product Information
RASUVO 17.5 MG/0.35 ML AUTOINJ is a brand product labeled by Medexus Pharma Inc., priced at $409.9292 per ML under NDC 59137052504. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jul 10, 2014.
The High Outlier badge above means this manufacturer's average price in the methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
17.5 mg/.35mL
Manufacturer
Medexus Pharma Inc.NDC
59137052504
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
4/1/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA205776FDA Approved
7/10/2014
On Market Since
7/10/2014
Pharmacological Classes
Price Statistics
The NADAC for RASUVO 17.5 MG/0.35 ML AUTOINJ has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $409.9292 per ML |
|---|---|
| All-time high | $409.9292 (Aug 19, 2026) |
| All-time low | $389.1064 (Feb 19, 2025) |
| 52-week high | $409.9292 |
| 52-week low | $399.4667 |
| Median price | $399.6112 |
| Average price | $397.8179 |
| Largest weekly change | +3.0% (Apr 2, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RASUVO 17.5 MG/0.35 ML AUTOINJ?
The current National Average Drug Acquisition Cost (NADAC) for RASUVO 17.5 MG/0.35 ML AUTOINJ, manufactured by Medexus Pharma Inc., is $409.9292 per ML (NDC 59137052504), effective Aug 19, 2026.
How has the price of RASUVO 17.5 MG/0.35 ML AUTOINJ changed over time?
Over the history we have for it, the NADAC for RASUVO 17.5 MG/0.35 ML AUTOINJ has risen 5.2%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for RASUVO 17.5 MG/0.35 ML AUTOINJ?
Since Apr 17, 2024, the NADAC for RASUVO 17.5 MG/0.35 ML AUTOINJ has ranged from a low of $389.1064 (Feb 19, 2025) to a high of $409.9292 (Aug 19, 2026), with a median of $399.6112 per ML.
Are there cheaper alternatives to RASUVO 17.5 MG/0.35 ML AUTOINJ?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RASUVO 17.5 MG/0.35 ML AUTOINJ in a comparable dosage form, but none are currently priced below it.
Who manufactures RASUVO 17.5 MG/0.35 ML AUTOINJ?
RASUVO 17.5 MG/0.35 ML AUTOINJ (NDC 59137052504) is labeled by Medexus Pharma Inc., and CMS classifies it as a brand product.